DART Therapeutics appointed Eugene W. Williams as CEO, Ernest D. Bush, Ph.D., as CSO, Elliot Goldstein, M.D., as CMO, and Cabot Brown as CFO...AMRI promoted Daniel Conlon to senior director of business development and elected Michael Nolan as vp, CFO, and treasurer.
Brett Haumann, M.D., is now CMO at Circassia...ChanTest hired Chris Mathes as CCO...Will Lewis is now president and CEO at Insmed...Visterra added Donna M. Ambrosino, M.D., as CMO...Aptiv Solutions appointed Scott Gottlieb, M.D., to its board of directors.
InVivo Therapeutics appointed Arthur J. Coury, Ph.D., to its business advisory board...Osmotica Pharmaceutical hired Darren Alkins as evp...Retrophin named Stephen Aselage as CEO...Thomas Pitler, Ph.D., is now vp of business development at A.P. Pharma.
Tobira Therapeutics added Caroline Loewy as evp and CFO, Jeff Enejosa, M.D., as senior director of clinical research, and Mark Menning as director of pharmaceutical sciences...Patrick Gallagher joined Kinex Pharmaceuticals as vp of business development and investor relations...CMC Biologics hired Mark W. Sawicki as vp of global business development.
Nuovo Biologics appointed Robert G. Savage to its board...Amgen named Ray Jordan as svp, corporate affairs...Christopher Allen Michaels has joined Rapid Pathogen Screening as vp of strategic development and technology licensing...Teva Pharmaceutical hired Jonathan L. Isaacsohn, M.D., as CMO...Merz added Cynthia Schwalm as vp, neurology...Transgenomic appointed Mark P. Colonnese as CFO.
Christine E. Garnett is now principal scientist at Certara...Illumina added Paul Bianchi as svp of human resources...Kane Biotech appointed Gord Froehlich to its board of directors...Circassia hired Stewart Sharpe as vp of commercial operations...Northwest Biotherapeutics added Günter Rosskamp, Ph.D., as CEO of its German subsidiary...Vertex named Yuchun Lee to its board of directors.